This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Feb 1;26(2):93-95.

doi: 10.5588/ijtld.21.0683.

Improving outcomes for multidrug-resistant TB treatment

D R Silva¹, F C de Queiroz Mello²

Affiliations

Affiliations

¹ Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
² Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

PMID: 35086619
DOI: 10.5588/ijtld.21.0683

Editorial

Improving outcomes for multidrug-resistant TB treatment

D R Silva et al. Int J Tuberc Lung Dis. 2022.

. 2022 Feb 1;26(2):93-95.

doi: 10.5588/ijtld.21.0683.

Authors

D R Silva¹, F C de Queiroz Mello²

Affiliations

¹ Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
² Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

PMID: 35086619
DOI: 10.5588/ijtld.21.0683

No abstract available

PubMed Disclaimer

Comment on

Determinants of treatment outcomes in patients with multidrug-resistant TB.
Burhan E, Soepandi PZ, Isbaniah F, Damayanti K, Edwar SQ, Maruli MF, Ralena NA, Susanto AD. Burhan E, et al. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):126-132. doi: 10.5588/ijtld.21.0351. Int J Tuberc Lung Dis. 2022. PMID: 35086624

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc